help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 8, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2825
A more recent version of this article appeared on November 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/11/4260    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ayturk, S.
Right arrow Articles by Guvener Demirag, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ayturk, S.
Right arrow Articles by Guvener Demirag, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*GLUCOSE
*PARATHYROID HORMONE

Submitted on December 27, 2005
Accepted on August 2, 2006

Changes in Insulin Sensitivity and Glucose and Bone Metabolism over Time in Patients with Asymptomatic Primary Hyperparathyroidism

Semra Ayturk, Alptekin Gursoy*, Neslihan Bascil Tutuncu, Derun Taner Ertugrul, and Nilgun Guvener Demirag

Baskent University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey

* To whom correspondence should be addressed. E-mail: alptekingursoy{at}hotmail.com.

Objective: The clinical profile of asymptomatic primary hyperparathyroidism (PHPT) had shifted from a symptomatic disorder toward a more subtle, asymptomatic state. The lack of knowledge about the natural course of asymptomatic PHPT contributes to the controversy regarding the optimal management of these patients. The aim of this study is to evaluate the natural course of calcium and glucose metabolism abnormalities, insulin sensitivity, and bone mineral density (BMD) in subjects with asymptomatic PHPT over 18 months.

Design: The study was designed as a prospective observational examination of asymptomatic PHPT patients at baseline and at 6-month intervals for 18 months.

Methods: Our study examined 61 patients with asymptomatic PHPT and 80 healthy control subjects matched for age, sex, and body mass index. We evaluated calcium metabolism, glucose metabolism by oral glucose tolerance test, insulin sensitivity by homeostasis model assessment (HOMA) index, and BMD by dual energy x-ray absorptiometry at distal radius, lumbar spine, and femur.

Results: Although in asymptomatic PHPT patients HOMA index at baseline was slightly higher than in controls (3.0 ± 2.2 vs. 2.2 ± 1.3, P = 0.035), the prevalence of preexisting diabetes mellitus (DM) (13.1% vs. 11.3%), undiagnosed impaired fasting glucose (34.4% vs. 30%), impaired glucose tolerance (13.1% vs. 18.8%), and newly diagnosed DM (4.9% vs. 2.5%) were similar. Baseline BMDs (g/cm2) at all three sites were not different between two groups. Six-month interval measurements showed no change in calcium metabolism parameters including serum calcium, phosphorus, 25-hydroxyvitamin D, and 24-hour calcium excretion. No significant longitudinal adverse changes were noted in glucose metabolism, insulin sensitivity, or BMD at any site over the 18-month observation period.

Conclusions: Our follow-up of patients with asymptomatic PHPT revealed no progression of calcium and glucose metabolism abnormalities, insulin sensitivity, and loss of bone mineral density during the 18-month study period.


Key words: primary hyperparathyroidism • asymptomatic • normocalcemic • natural course • insulin sensitivity • calcium • glucose metabolism • bone mineral density







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society